Hoffmann-La Roche, Inc.
United StatesFDA applicant, unverified
- Devices
- 50
What Hoffmann-La Roche, Inc. makes
The company produces in-vitro diagnostic reagents and test kits for clinical laboratory use, including radioimmunoassay kits for substances like human chorionic gonadotropin (HCG) and amphetamines, as well as reagents for measuring calcium, creatinine, lactate dehydrogenase (CPK-CS), and barbiturates. It also supplies standards for calibrating creatinine assays and slide-based diagnostic tests for drug detection.
These products are regulated under the FDA’s in-vitro diagnostic device categories, with most classified as Class I or Class II, while some fall under Class U (unclassified). They are authorised via 510(k) clearances or Premarket Approval Applications (PMA) and are listed in the FDA’s regulatory databases. The company is based in the United States.
Catalogue
Search and filter all 50 devicesFrequently asked questions
How many devices does Hoffmann-La Roche, Inc. have in the registry?
The registry currently lists 50 devices for Hoffmann-La Roche, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Hoffmann-La Roche, Inc.'s devices?
Among its 50 most recently registered devices, Hoffmann-La Roche, Inc. has devices listed in FDA 510(k) (49 devices) and FDA PMA (1 device). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Hoffmann-La Roche, Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Hoffmann-La Roche, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Hoffmann-La Roche, Inc. in the registry?
The most recently registered devices listed for Hoffmann-La Roche, Inc. include COBAS REAGENT FOR CALCIUM, TEST, IN-VITRO DIAGNOSTIC, HCG RADIOIMMUNOASSAY and COBAS STANDARDS FOR CREATININE.